Skip to main content
SpringerLink
Log in

The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

In MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and 6-hydroxydopamine induced dopaminergic neurotoxicity and Parkinson’s disease iron accumulates in substantia nigra pars compacta which has been suggested to participate in oxidative stress induced neurodegeneration. Pretreatment with iron chelators desferal, clioquinol, VK-28 and M30 are neuroprotective in both models. To determine the specificity of chelation neuroprotective activity we have examined the effect of D-penicillamine, a relatively specific copper chelator, in the mice model of MPTP-induced dopamine depletion. Our studies show that D-penicillamine, employed for removal of copper in Wilson disease is relatively weak in preventing dopaminergic neurotoxicity induced by MPTP, as compared to iron chelators previously studied. The results indicate that for prevention of MPTP-induced dopamine depletion and dopamine neurodegeneration, iron rather than copper chelation may be more effective and specific.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • D Acuna-Castrovie A Coto-Montes M Gaia Monti GG Ortiz RJ Reiter (1997) ArticleTitleMelatonin is protective against MPTP-induced striatal and hippocampal lesions Life Sci 60 L23–L29

    Google Scholar 

  • M Alcaraz-Zubeldia P Rojas C Boll C Rios (2001) ArticleTitleNeuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice Neurochem Res 26 59–64 Occurrence Handle11358283 Occurrence Handle10.1023/A:1007680616056 Occurrence Handle1:CAS:528:DC%2BD3MXjsVynt78%3D

    Article  PubMed  CAS  Google Scholar 

  • G Battaglia CL Busceti L Cuomo FS Giorgi F Orzi A De Blasi F Nicoletti S Ruggieri F Fornai (2002) ArticleTitleContinuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice Neuropharmacology 42 367–373 Occurrence Handle11897115 Occurrence Handle10.1016/S0028-3908(01)00178-2 Occurrence Handle1:CAS:528:DC%2BD38XhvVCjsL4%3D

    Article  PubMed  CAS  Google Scholar 

  • D Ben-Shachar G Eshel JP Finberg MB Youdim (1991) ArticleTitleThe iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons J Neurochem 56 1441–1444 Occurrence Handle1900527 Occurrence Handle10.1111/j.1471-4159.1991.tb11444.x Occurrence Handle1:CAS:528:DyaK3MXisVSnsLY%3D

    Article  PubMed  CAS  Google Scholar 

  • D Ben-Shachar N Kahana V Kampel A Warshawsky MB Youdim (2004) ArticleTitleNeuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats Neuropharmacology 46 254–263 Occurrence Handle10.1016/j.neuropharm.2003.09.005 Occurrence Handle1:CAS:528:DC%2BD3sXpvVWgsLo%3D

    Article  CAS  Google Scholar 

  • D Berg M Gerlach MB Youdim KL Double L Zecca P Riederer G Becker (2001) ArticleTitleBrain iron pathways and their relevance to Parkinson’s disease J Neurochem 79 225–236 Occurrence Handle11677250 Occurrence Handle10.1046/j.1471-4159.2001.00608.x Occurrence Handle1:CAS:528:DC%2BD3MXnvFSmsr8%3D

    Article  PubMed  CAS  Google Scholar 

  • S Bharath M Hsu D Kaur S Rajagopalan JK Andersen (2002) ArticleTitleGlutathione, iron and Parkinson’s disease Biochem Pharmacol 64 1037–1048 Occurrence Handle12213603 Occurrence Handle10.1016/S0006-2952(02)01174-7 Occurrence Handle1:CAS:528:DC%2BD38Xms1ymsbw%3D

    Article  PubMed  CAS  Google Scholar 

  • GJ Brewer (2005) ArticleTitleNeurologically presenting Wilson’s disease: epidemiology, pathophysiology and treatment CNS Drugs 19 185–192 Occurrence Handle15740174 Occurrence Handle10.2165/00023210-200519030-00001 Occurrence Handle1:CAS:528:DC%2BD2MXjt1Cksbs%3D

    Article  PubMed  CAS  Google Scholar 

  • JL Cadet M Katz V Jackson-Lewis S Fahn (1989) ArticleTitleVitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats:behavioral and biochemical evidence Brain Res 476 10–15 Occurrence Handle2492442 Occurrence Handle10.1016/0006-8993(89)91530-8 Occurrence Handle1:CAS:528:DyaL1MXlt1Gktw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • G Cohen (2000) ArticleTitleOxidative stress, mitochondrial respiration, and Parkinson’s disease Ann N Y Acad Sci 899 112–120 Occurrence Handle10863533 Occurrence Handle1:CAS:528:DC%2BD3cXks1Shs70%3D Occurrence Handle10.1111/j.1749-6632.2000.tb06180.x

    Article  PubMed  CAS  Google Scholar 

  • A Crowe EH Morgan (1996) ArticleTitleThe effects of iron loading and iron deficiency on the tissue uptake of 64Cu during development in the rat Biochim Biophys Acta 1291 53–59 Occurrence Handle8781525

    PubMed  Google Scholar 

  • DT Dexter FR Wells AJ Lees F Agid Y Agid P Jenner CD Marsden (1989a) ArticleTitleIncreased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease J Neurochem 52 1830–1836 Occurrence Handle10.1111/j.1471-4159.1989.tb07264.x Occurrence Handle1:CAS:528:DyaL1MXkslGrs7k%3D

    Article  CAS  Google Scholar 

  • DT Dexter CJ Carter FR Wells F Javoy-Agid Y Agid A Lees P Jenner CD Marsden (1989b) ArticleTitleBasal lipid peroxidation in substantia nigra is increased in Parkinson’s disease J Neurochem 52 381–389 Occurrence Handle10.1111/j.1471-4159.1989.tb09133.x Occurrence Handle1:CAS:528:DyaL1MXhtFalsrc%3D

    Article  CAS  Google Scholar 

  • D Di Monte MS Sandy MT Smith (1987) ArticleTitleIncreased efflux rather than oxidation is the mechanism of glutathione depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Biochem Biophys Res Commun 148 153–160 Occurrence Handle3499902 Occurrence Handle10.1016/0006-291X(87)91089-8 Occurrence Handle1:CAS:528:DyaL2sXmtlSrtrs%3D

    Article  PubMed  CAS  Google Scholar 

  • TN Ferraro GT Golden M DeMattei TA Hare RG Fariello (1986) ArticleTitleEffect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse Neuropharmacology 25 1071–1074 Occurrence Handle2430229 Occurrence Handle10.1016/0028-3908(86)90205-4 Occurrence Handle1:CAS:528:DyaL28XlslSjsro%3D

    Article  PubMed  CAS  Google Scholar 

  • S Gal H Zheng M Fridkin MBH Youdim (2005) ArticleTitleNovel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion J Neurochem 95 77–88 Occurrence Handle10.1111/j.1471-4159.2005.03341.x Occurrence Handle1:CAS:528:DC%2BD2MXhtVygs7bF

    Article  CAS  Google Scholar 

  • M Gassen A Gross MBH Youdim (1998) ArticleTitleApomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine Mov Disord 13 242–248 Occurrence Handle9539336 Occurrence Handle10.1002/mds.870130208 Occurrence Handle1:STN:280:DyaK1c7pvVOnsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Gassen Y Glinka B Pinchasi MBH Youdim (1996) ArticleTitleApomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction Eur J Pharmacol 308 219–225 Occurrence Handle8840135 Occurrence Handle10.1016/0014-2999(96)00291-9 Occurrence Handle1:CAS:528:DyaK28Xkt12rtb0%3D

    Article  PubMed  CAS  Google Scholar 

  • M Gerlach D Ben-Shachar P Riederer MBH Youdim (1994) ArticleTitleAltered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 79 793–807

    Google Scholar 

  • E Grassmann M Kirchgessner JJ Kim (1983) ArticleTitleFe and Cu content in the liver, spleen, kidney and heart of growing rats with variable Fe and Cu supply Z Ernahrungswiss 22 124–137 Occurrence Handle6880294 Occurrence Handle10.1007/BF02026209 Occurrence Handle1:CAS:528:DyaL3sXktlOgtbc%3D

    Article  PubMed  CAS  Google Scholar 

  • E Grünblatt S Mandel T Berkuzki MBH Youdim (1999) ArticleTitleApomorphine protects against MPTP-induced neurotoxicity in mice Mov Disord 14 612–618 Occurrence Handle10435498 Occurrence Handle10.1002/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6

    Article  PubMed  Google Scholar 

  • E Grünblatt S Mandel G Maor MBH Youdim (2001) ArticleTitleEffects ofR-apomorphine and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss J Neurochem 77 146–156 Occurrence Handle11279270 Occurrence Handle10.1046/j.1471-4159.2001.t01-1-00227.x

    Article  PubMed  Google Scholar 

  • S Hall JN Rutledge T Schallert (1992) ArticleTitleMRI, brain iron and experimental Parkinson’s disease J Neurol Sci 113 198–208 Occurrence Handle1487755 Occurrence Handle10.1016/0022-510X(92)90247-I Occurrence Handle1:CAS:528:DyaK3sXhsVCqu7w%3D

    Article  PubMed  CAS  Google Scholar 

  • B Halliwell (2001) ArticleTitleRole of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment Drugs Aging 18 685–716 Occurrence Handle11599635 Occurrence Handle10.2165/00002512-200118090-00004 Occurrence Handle1:CAS:528:DC%2BD3MXnvVCiur4%3D

    Article  PubMed  CAS  Google Scholar 

  • K Jellinger W Paulus I Grundke-Iqbal P Riederer MBH Youdim (1990) ArticleTitleBrain iron and ferritin in Parkinson’s and Alzheimer’s diseases J Neural Transm Park Dis Dement Sect 2 327–340 Occurrence Handle2078310 Occurrence Handle10.1007/BF02252926 Occurrence Handle1:CAS:528:DyaK3MXlsFKgtbg%3D

    Article  PubMed  CAS  Google Scholar 

  • K Jellinger E Kienzel G Rumpelmair P Riederer H Stachelberger D Ben-Shachar MBH Youdim (1992) ArticleTitleIron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis J Neurochem 59 1168–1171 Occurrence Handle1494904 Occurrence Handle10.1111/j.1471-4159.1992.tb08362.x Occurrence Handle1:CAS:528:DyaK38Xls1yrsL8%3D

    Article  PubMed  CAS  Google Scholar 

  • P Jenner CW Olanow (1996) ArticleTitleOxidative stress and the pathogenesis of Parkinson’s disease Neurology 47 S161–S170 Occurrence Handle8959985 Occurrence Handle1:STN:280:DyaK2s7hvFWlsA%3D%3D

    PubMed  CAS  Google Scholar 

  • D Kaur F Yantiri S Rajagopalan J Kumar JQ Mo R Boonplueang V Viswanath R Jacobs L Yang MF Beal D DiMonte I Volitaskis L Ellerby RA Cherny AI Bush J Anderson (2003) ArticleTitleGenetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson’s disease Neuron 37 899–909 Occurrence Handle12670420 Occurrence Handle10.1016/S0896-6273(03)00126-0 Occurrence Handle1:CAS:528:DC%2BD3sXivFWkurg%3D

    Article  PubMed  CAS  Google Scholar 

  • DM Kaye S Gruskin AI Smith MD Esler (2000) ArticleTitleNitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation Br J Pharmacol 130 1060–1064 Occurrence Handle10882390 Occurrence Handle10.1038/sj.bjp.0703416 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Slu70%3D

    Article  PubMed  CAS  Google Scholar 

  • G Kunikowska P Jenner (2002) ArticleTitleThe distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal ganglia Biochem Pharmacol 63 1159–1164 Occurrence Handle11931849 Occurrence Handle10.1016/S0006-2952(01)00897-8 Occurrence Handle1:CAS:528:DC%2BD38XisFWnt78%3D

    Article  PubMed  CAS  Google Scholar 

  • J Lan DH Jiang (1997) ArticleTitleDesferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice J Neural Transm 104 469–481 Occurrence Handle9295179 Occurrence Handle10.1007/BF01277665 Occurrence Handle1:CAS:528:DyaK2sXmt1SrsrY%3D

    Article  PubMed  CAS  Google Scholar 

  • L Leggio G Addolorato L Abenavoli G Gasbarrini (2005) ArticleTitleWilson’s disease: clinical, genetic and pharmacological findings Int J Immunopathol Pharmacol 18 7–14 Occurrence Handle15698506 Occurrence Handle1:CAS:528:DC%2BD2MXjtlakt7w%3D

    PubMed  CAS  Google Scholar 

  • H Mochizuki H Imai K Endo K Yokomizo Y Murata N Hattori Y Mizuno (1994) ArticleTitleIron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys Neurosci Lett 168 251–253 Occurrence Handle8028787 Occurrence Handle10.1016/0304-3940(94)90462-6 Occurrence Handle1:CAS:528:DyaK2cXivFGrs7s%3D

    Article  PubMed  CAS  Google Scholar 

  • S Moussaoui MC Obinu N Daniel M Reibaud V Blanchard A Imperato (2000) ArticleTitleThe antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson’s disease Exp Neurol 166 235–245 Occurrence Handle11085889 Occurrence Handle10.1006/exnr.2000.7516 Occurrence Handle1:CAS:528:DC%2BD3cXotFCrsLY%3D

    Article  PubMed  CAS  Google Scholar 

  • E Oestreicher GJ Sengstock P Riederer CW Olanow AJ Dunn GW Arendash (1994) ArticleTitleDegeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study Brain Res 660 8–18 Occurrence Handle7828004 Occurrence Handle10.1016/0006-8993(94)90833-8 Occurrence Handle1:CAS:528:DyaK2cXmsFaqtb4%3D

    Article  PubMed  CAS  Google Scholar 

  • E Pileblad T Magnusson B Fornstedt (1989) ArticleTitleReduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum J Neurochem 52 978–980 Occurrence Handle2493072 Occurrence Handle10.1111/j.1471-4159.1989.tb02550.x Occurrence Handle1:CAS:528:DyaL1MXht12isb8%3D

    Article  PubMed  CAS  Google Scholar 

  • P Riederer E Sofic WD Rausch B Schmidt GP Reynolds K Jellinger MBH Youdim (1989) ArticleTitleTransition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J Neurochem 52 515–520 Occurrence Handle2911028 Occurrence Handle10.1111/j.1471-4159.1989.tb09150.x Occurrence Handle1:CAS:528:DyaL1MXhtFals78%3D

    Article  PubMed  CAS  Google Scholar 

  • C Rios R Alvarez-Vega P Rojas (1995) ArticleTitleDepletion of copper and manganese in brain after MPTP treatment of mice Pharmacol Toxicol 76 348–352 Occurrence Handle7479574 Occurrence Handle1:CAS:528:DyaK2MXmt1ajtL0%3D Occurrence Handle10.1111/j.1600-0773.1995.tb00160.x

    Article  PubMed  CAS  Google Scholar 

  • TA Seaton P Jenner CD Marsden (1996) ArticleTitleThioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain J Neural Transm 103 315–329 Occurrence Handle8739843 Occurrence Handle10.1007/BF01271243 Occurrence Handle1:CAS:528:DyaK28XjslensLk%3D

    Article  PubMed  CAS  Google Scholar 

  • J Sian DT Dexter AJ Lees S Daniel Y Agid F Javoy-Agid P Jenner CD Marsden (1994) ArticleTitlelterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 348–355 Occurrence Handle8080242 Occurrence Handle10.1002/ana.410360305 Occurrence Handle1:STN:280:DyaK2czmtFCltg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • E Sofic P Riederer H Heinsen H Beckmann GP Reynolds G Hebenstreit MBH Youdim (1988) ArticleTitleIncreased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain J Neural Transm 74 199–205 Occurrence Handle3210014 Occurrence Handle10.1007/BF01244786 Occurrence Handle1:STN:280:DyaL1M%2FpsVegsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • JA Temlett JP Landsberg F Watt GW Grime (1994) ArticleTitleIncreased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis J Neurochem 62 134–146 Occurrence Handle8263513 Occurrence Handle1:CAS:528:DyaK2cXnsVOmug%3D%3D Occurrence Handle10.1046/j.1471-4159.1994.62010134.x

    Article  PubMed  CAS  Google Scholar 

  • MB Youdim D Ben-Shachar P Riederer (1993) ArticleTitleThe possible role of iron in the etiopathology of Parkinson’s disease Mov Disord 8 1–12 Occurrence Handle8419792 Occurrence Handle10.1002/mds.870080102 Occurrence Handle1:STN:280:DyaK3s7isFGrtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • MB Youdim G Stephenson D Ben Shachar (2004) ArticleTitleIroning iron out in Parkinson’s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28 Ann N Y Acad Sci 1012 306–325 Occurrence Handle15105275 Occurrence Handle10.1196/annals.1306.025 Occurrence Handle1:CAS:528:DC%2BD2cXjvVOms7s%3D

    Article  PubMed  CAS  Google Scholar 

  • L Zecca MB Youdim P Riederer JR Connor RR Crichton (2004) ArticleTitleIron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 5 863–873 Occurrence Handle15496864 Occurrence Handle10.1038/nrn1537 Occurrence Handle1:CAS:528:DC%2BD2cXos1Ojtrc%3D

    Article  PubMed  CAS  Google Scholar 

  • H Zheng LM Weiner O Bar-Am S Epsztejn ZI Cabantchik A Warshawsky MB Youdim M Fridkin (2005) ArticleTitleDesign, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer’s, Parkinson’s, and other neurodegenerative diseases Bioorg Med Chem 13 773–778 Occurrence Handle15653345 Occurrence Handle10.1016/j.bmc.2004.10.037 Occurrence Handle1:CAS:528:DC%2BD2MXksVamtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eve Topf and US National Parkinson Foundation, Centers of Excellence For Neurodegenerative Diseases Research, Technion-Rappaport Family Faculty of Medicine, Haifa, Israel

    E. Grünblatt & S. Mandel

Authors
  1. M. B. H. Youdim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Grünblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Mandel
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Present address: Institute of Clinical Neurochemistry and National Parkinson Foundation Center of Excellence, Department of Psychiatry, University of Würzburg, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Youdim, M., Grünblatt, E. & Mandel, S. The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice. J Neural Transm 114, 205–209 (2007). https://doi.org/10.1007/s00702-006-0499-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-006-0499-1

Search

Navigation